WebDec 26, 2024 · The DermTech Melanoma Test is a precision genomic test that lets us look past the skin’s cells — deep within skin’s genes — to help find and assess disease earlier. “If detected early, the five-year survival rate for melanoma can be as high as 99 percent . WebDermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, …
This Insider Has Just Sold Shares In DermTech, Inc. (NASDAQ…
WebApr 11, 2024 · 5 Wall Street research analysts have issued 1-year price objectives for DermTech's stock. Their DMTK share price forecasts range from $5.00 to $23.00. On average, they predict the company's share price to reach $10.00 in the next year. This suggests a possible upside of 161.8% from the stock's current price. View analysts price … WebSun joined DermTech Operations in August 2024 and served in the role of Vice President, Finance. From June 2008 to November 2024, Mr. Sun served in various management and executive roles for Dexcom, Inc. (Nasdaq:DXCM) including most recently as Vice President, Corporate Controller and Treasury from November 2024 to November 2024, as Interim ... darkest dungeon running in slow motion
Carolyn Carter - Regional Sales Manager - DermTech …
WebApr 3, 2024 · DMTK Complete DermTech Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebJan 23, 2024 · About DermTech. DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non … WebDec 30, 2024 · Shares of DermTech ( DMTK 2.99%) were soaring 25.4% higher as of 10:57 a.m. EST on Wednesday. The impressive jump came after the company announced that Geisinger Health System issued a positive ... bishnoi agro